PCSK9 and viral infectious disease: In hypoxic microenvironments, upregulation of PCSK9 induced by dengue virus reduces LDLR-mediated uptake of LDL cholesterol and augments virus infection by promoting de novo cholesterol synthesis in the endoplasmic reticulum, which inhibits STING-mediated antiviral response (39).